Thus, we will utilize AngII to construct an in vitro fibrosis model in order to demonstrate the inhibitory effect of HBI‐8000 on myocardial fibrosis and to determine its potential mechanism of action. This evidence concerns the gene AGT and Myocardial fibrosis.